Clinical Trial: Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection
Study Status: Completed
Recruit Status: RECRUITING
Condition: Diabetic Foot Infection
Study Type: INTERVENTIONAL
Official Title: A Phase 2 CT to Evaluate the Safety and Efficacy of Topical Administration of Bacteriophage Therapy TP-102 in Patients With DFI
Brief Summary:
TP-102 is a novel bacteriophage cocktail comprised of 5 (five) lytic bacteriophages against Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii.TP-102 is being developed for topical treatment of patients with wound infections including chronic ulcers; applied every other day (three times weekly (TIW)).
Read more